Europe Oligonucleotide Synthesis Market Analysis and Opportunities by 2027

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

Europe Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users)

  • Report Code : TIPRE00007128
  • Category : Life Sciences
  • No. of Pages : 163
Buy Now

The Europe Oligonucleotide Synthesis market is expected to reach US$ $ 1,270.95 Mn in 2027 from US$ 518.02 Mn in 2018. The market is estimated to grow with a CAGR of 13.7% from 2019-2027.

The growth of the market is driven by the factors such as, research and academic universities are collaborating with commercial market players to develop techniques and simplify the method of artificial DNA synthesis as well as rise in the number of market players and their focus in the oligonucleotide synthesis are likely to boost the growth of the oligonucleotide synthesis in the region during the forecast period.

Synthetic DNA is widely used in biology. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. Due to the simultaneous developments of methods for the rapid and efficient synthesis of oligonucleotides and the advent of molecular biology techniques.

Oligonucleotides have many applications in research, diseases diagnosis, therapeutics, forensic, drug discovery, agriculture and many more. Synthetic oligonucleotides are widely used in the diagnosis of human genetic diseases. In addition, the players operating in the UK oligonucleotide synthesis market have been obtaining funds in order to enhance their product offering. For instance, in March, 2019, UK based privately held biotech company, Procarta Biosystems received a fund of US$ 1.69 Mn (€1.5 m) from the Novo Holdings REPAIR Impact Fund in order to enable the development of novel therapies to combat antimicrobial resistance (AMR).

Researchers are also using oligonucleotides to produce more efficient, greener chemical synthesis. By assembling oligonucleotides together into longer fragments that encode synthetic genes, bacteria or yeast cells can be instructed to produce specific enzymes (a type of protein).

Oligonucleotides also has wide potential for treating various medical conditions. They enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. For instance, Ionis Pharmaceuticals has dedicated its existence to oligonucleotide therapeutic development, particularly antisense oligonucleotide (ASO) therapeutics. Thus, the promising potential of synthesized oligonucleotides in various fields drives the market growth.

Spain is expected to lead the market in the Europe region owing to growing number of partnerships and collaborations among private players, rising investments and funding dedicated to the biotechnology companies as well as academic and research institutes for gene synthesis based end products. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.

Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION

By Product

  • Synthesized Oligonucleotides
    • Primers
    • Probes
    • Large-Scale Synthesis
    • Others
  • Reagents
    • Equipment

By Application

  • Research
  • Diagnostics
  • Therapeutics

By End User

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users

By Geography

  • Europe

    • US
    • Canada
    • Mexico

Company Profiles

  • Thermo Fisher Scientific Inc.
  • GenScript
  • Molecular Assemblies
  • Twist Biosciences
  • Evonetix
  • DNA Script
  • Nuclera Nucleics
  • Camena Bioscience
  • Synthomics
  • Ansa Biotechnologies

Europe Oligonucleotide Synthesis Report Scope

Report Attribute Details
Market size in 2018 US$ 518.02 Million
Market Size by 2027 US$ $ 1,270.95 Million
Global CAGR (2019 - 2027) 13.7%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product
  • Synthesized Oligonucleotides
  • Reagents
  • Equipment
By Application
  • Research
  • Diagnostics
  • Therapeutics
By End User
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • GenScript
  • Molecular Assemblies
  • Twist Biosciences
  • Evonetix
  • DNA Script
  • Nuclera Nucleics
  • Camena Bioscience
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    europe-oligonucleotide-synthesis-market-report-deliverables-img1
    europe-oligonucleotide-synthesis-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Product, Application, End User

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    UK, Germany, France, Italy, Russia

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Europe Oligonucleotide Synthesis Market
    Connect With Expert

    The List of Companies

     

    1. Thermo Fisher Scientific Inc.
    2. GenScript
    3. Molecular Assemblies
    4. Twist Biosciences
    5. Evonetix
    6. DNA Script
    7. Nuclera Nucleics
    8. Camena Bioscience
    9. Synthomics
    10. Ansa Biotechnologies
    europe-oligonucleotide-synthesis-market-cagr